AKT-1, -2, and -3 are expressed in both normal and tumor tissues of the lung, breast, prostate, and colon.
about
Analysis of CUL-5 expression in breast epithelial cells, breast cancer cell lines, normal tissues and tumor tissuesThe actin-bundling protein palladin is an Akt1-specific substrate that regulates breast cancer cell migrationLigand-free estrogen receptor activity complements IGF1R to induce the proliferation of the MCF-7 breast cancer cells.Akt2 inhibition enables the forkhead transcription factor FoxO3a to have a repressive role in estrogen receptor alpha transcriptional activity in breast cancer cells.rSW-seq: algorithm for detection of copy number alterations in deep sequencing data.Epidermal Growth Factor Receptor Cell Proliferation Signaling PathwaysEupolyphaga sinensis walker displays inhibition on hepatocellular carcinoma through regulating cell growth and metastasis signaling.Membrane Trafficking of Collecting Duct Water Channel Protein AQP2 Regulated by Akt/AS160.Inhibition of Akt with small molecules and biologics: historical perspective and current status of the patent landscape.Imidazo[1,2-a]pyridine-based peptidomimetics as inhibitors of Akt.Discovery of Akt kinase inhibitors through structure-based virtual screening and their evaluation as potential anticancer agents.Cbl-b-regulated extracellular signal-regulated kinase signaling is involved in the shikonin-induced apoptosis of lung cancer cells in vitro.Akt activation and localisation correlate with tumour invasion and oncogene expression in thyroid cancer.The prognostic impact of Akt isoforms, PI3K and PTEN related to female steroid hormone receptors in soft tissue sarcomas.Akt2 knock-down reveals its contribution to human lung cancer cell proliferation, growth, motility, invasion and endothelial cell tube formationA novel angiogenesis inhibitor impairs lovo cell survival via targeting against human VEGFR and its signaling pathway of phosphorylationAKT3 promotes prostate cancer proliferation cells through regulation of Akt, B-Raf, and TSC1/TSC2.Genetics of melanomaExpression and localisation of Akt-1, Akt-2 and Akt-3 correlate with clinical outcome of prostate cancer patients.A splice variant of HER2 corresponding to Herstatin is expressed in the noncancerous breast and in breast carcinomas.Targeting the PI3K/Akt/mTOR pathway: effective combinations and clinical considerations.Effect of Akti-2 on sperm motility, capacitation and acrosome reaction in a mouse modelMolecular targets of breast cancer: AKTing in concertTargeting the PI3-kinase/Akt/mTOR signaling pathway.Differential Receptor Tyrosine Kinase PET Imaging for Therapeutic Guidance.Impaired translocation and activation of mitochondrial Akt1 mitigated mitochondrial oxidative phosphorylation Complex V activity in diabetic myocardium.A Low-Frequency Inactivating AKT2 Variant Enriched in the Finnish Population Is Associated With Fasting Insulin Levels and Type 2 Diabetes Risk.Discovery and Evaluation of Polymorphisms in the AKT2 and AKT3 Promoter Regions for Risk of Korean Lung Cancer.Dihydroberberine exhibits synergistic effects with sunitinib on NSCLC NCI-H460 cells by repressing MAP kinase pathways and inflammatory mediatorsAmplification of Chromosome 1q Genes Encoding the Phosphoinositide Signalling Enzymes PI4KB, AKT3, PIP5K1A and PI3KC2B in Breast Cancer.
P2860
Q24806313-75801465-F474-4062-85F2-57E44AE346A7Q30494570-C1F5CD37-D3EF-42F9-A7F2-874E4586C5B5Q31073908-B91038EF-B35F-4EB7-BE84-C128C474EC66Q33614071-5D1473C0-4DBD-4AE9-986B-E8331B004832Q33662745-8880FBD4-BD9E-43E7-AD6A-03C0A0718624Q33737298-3B3131D9-290D-43C1-8087-70BE2D9B1993Q33827192-84E609EA-5D1F-4FAE-90EA-950AEEBFE2CEQ33863522-87DA8629-3690-4EEB-A951-580E5DB81E9CQ33920097-BBC8C028-525B-4D94-ADB6-2E66AD8FA382Q34250369-88D5023F-64C4-4BF1-BA01-CA42778A92ACQ35139006-D39F986B-615F-4398-96B9-E88C0C087310Q35159711-18E10F4A-35CD-4D5F-BADC-2C6738F47E93Q35445077-61BD4DE9-43CC-4AAE-91BA-29D7DE1F6F1EQ35661688-7DF486F6-5F70-47D4-991F-79629817AD0DQ35909804-F6ADAB47-E244-4BA7-A993-68F9F6F9EDA8Q36347241-24C50EF8-531D-46F1-8513-CD6D6D06B14CQ36413704-F981153A-186F-446E-835C-F310D41E9D4EQ36563659-8F17354A-C730-4656-B5F0-FF88047A962BQ36614450-DB7F0E91-EAF3-4C71-A39E-806755B93A79Q36730394-82A9436F-88C8-4D62-9B01-6907B6EB025FQ36742629-48093D26-CCE1-45F1-897D-563F55384B62Q36824601-4B115EB7-E16C-4093-B9CA-85C92D7740F5Q37183674-ADEE9703-04C0-4CA5-B373-7699DB825C08Q37265126-9D01563A-0E72-4A1D-9930-D2535E94C894Q37390681-242F85B3-A22D-47CE-8806-901ACEA071A2Q37413596-47E85144-F825-4298-8669-97A7E7EE700DQ38877389-F71B4639-9CD4-4A4F-A611-EE6ECF04341AQ41363686-BFCA5F21-001E-496D-B6E3-502E348FD897Q41952858-C19E8B1E-684A-45B9-BDB1-3FE88070E2ECQ42971476-8B375FC1-24D8-414F-A2E6-277F4C070908
P2860
AKT-1, -2, and -3 are expressed in both normal and tumor tissues of the lung, breast, prostate, and colon.
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
AKT-1, -2, and -3 are expresse ...... , breast, prostate, and colon.
@ast
AKT-1, -2, and -3 are expresse ...... , breast, prostate, and colon.
@en
AKT-1, -2, and -3 are expresse ...... , breast, prostate, and colon.
@nl
type
label
AKT-1, -2, and -3 are expresse ...... , breast, prostate, and colon.
@ast
AKT-1, -2, and -3 are expresse ...... , breast, prostate, and colon.
@en
AKT-1, -2, and -3 are expresse ...... , breast, prostate, and colon.
@nl
prefLabel
AKT-1, -2, and -3 are expresse ...... , breast, prostate, and colon.
@ast
AKT-1, -2, and -3 are expresse ...... , breast, prostate, and colon.
@en
AKT-1, -2, and -3 are expresse ...... , breast, prostate, and colon.
@nl
P2093
P1476
AKT-1, -2, and -3 are expresse ...... g, breast, prostate, and colon
@en
P2093
B L Neubauer
B W Konicek
G Sandusky
J E Thomas
M A Johnson
P304
P407
P577
2001-08-01T00:00:00Z